CA2137755A1 - Attenuation des troubles a cellules falciformes par le phenyluree, le benzyluree ou le phenylethyluree ou par un homologue a substituant methoxyl, methyl ou hydroxyl sur le noyau - Google Patents

Attenuation des troubles a cellules falciformes par le phenyluree, le benzyluree ou le phenylethyluree ou par un homologue a substituant methoxyl, methyl ou hydroxyl sur le noyau

Info

Publication number
CA2137755A1
CA2137755A1 CA 2137755 CA2137755A CA2137755A1 CA 2137755 A1 CA2137755 A1 CA 2137755A1 CA 2137755 CA2137755 CA 2137755 CA 2137755 A CA2137755 A CA 2137755A CA 2137755 A1 CA2137755 A1 CA 2137755A1
Authority
CA
Canada
Prior art keywords
substituted
phenylethylurea
benzylurea
phenylurea
palliation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2137755
Other languages
English (en)
Other versions
CA2137755C (fr
Inventor
William H. Waugh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2137755A1 publication Critical patent/CA2137755A1/fr
Application granted granted Critical
Publication of CA2137755C publication Critical patent/CA2137755C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA 2137755 1994-06-07 1994-12-09 Attenuation des troubles a cellules falciformes par le phenyluree, le benzyluree ou le phenylethyluree ou par un homologue a substituant methoxyl, methyl ou hydroxyl sur le noyau Expired - Fee Related CA2137755C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25575594A 1994-06-07 1994-06-07
US08/255,755 1994-06-07

Publications (2)

Publication Number Publication Date
CA2137755A1 true CA2137755A1 (fr) 1995-12-08
CA2137755C CA2137755C (fr) 2002-07-02

Family

ID=22969714

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2137755 Expired - Fee Related CA2137755C (fr) 1994-06-07 1994-12-09 Attenuation des troubles a cellules falciformes par le phenyluree, le benzyluree ou le phenylethyluree ou par un homologue a substituant methoxyl, methyl ou hydroxyl sur le noyau

Country Status (2)

Country Link
CA (1) CA2137755C (fr)
GB (1) GB2290235B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696475B2 (en) 1997-04-22 2004-02-24 Neurosearch A/S Substituted phenyl derivatives, their preparation and use
KR100799892B1 (ko) * 1998-10-22 2008-01-31 뉴로서치 에이/에스 치환된 페닐 유도체 및 이를 포함하는 약제학적 조성물
DE102012007558A1 (de) 2012-04-14 2013-10-17 Alf Hammes Gabe substituierter bis-aryl-harnstoffderivate zur behandlung von anämien

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56131516A (en) * 1980-03-18 1981-10-15 Koutaku Hayashi Immunochemotherapy, prevention of resistance to drug, and carcinostatic agent

Also Published As

Publication number Publication date
GB2290235A (en) 1995-12-20
GB2290235B (en) 1998-03-25
GB9500442D0 (en) 1995-03-01
CA2137755C (fr) 2002-07-02

Similar Documents

Publication Publication Date Title
CA2186380A1 (fr) Nouveaux carbamates et urees utilises pour modifier la resistance multi-medicamenteuse
CA2010919A1 (fr) Cosmetiques en batonnets
AU7820191A (en) New imidazole derivatives, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them
CA2386690A1 (fr) Sels pharmaceutiques de tramadol
CA2007752A1 (fr) Gels oraux elastiques et extrudables et distributeurs de doses les contenant, methode de fabrication et methode d&#39;utilisation
IT8921118A0 (it) Composizione per aerosol comprendente nitroglicerina come ingrediente attivo.
FR2669225B1 (fr) Utilisation de saponines de medicago pour la preparation de compositions cosmetiques ou pharmaceutiques, notamment dermatologiques.
WO2001032646A3 (fr) Nouveaux composes
DE69104991D1 (de) Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen.
TW347335B (en) Solid silicone compositions and methods for their preparation and use
DE69904483D1 (de) Nitrat-salze als arzneimittel
ATE17725T1 (de) Gegen entzuendung wirksame 5-substituierte 2,3diaryl-thiophene, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
IT8221278A0 (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
IL116746A0 (en) Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions
WO1997004788A3 (fr) Utilisation de glycosides de calendula dans le traitement du psoriasis
DE68925080D1 (de) FR-901154- und FR-901155-Derivate, Verfahren zu ihrer Herstellung
DE68900029D1 (de) Pyrazolderivate, verfahren zu ihrer herstellung und diese derivate als aktive komponente enthaltende insektizide, mitizide und fungizide zusammensetzungen.
DE2966411D1 (en) Imidazolylvinylethers, their preparation and application as active agent in pharmaceutical and biocidal compositions
EP0657167A3 (fr) Application de l&#39;oenothéine B pour obtenir un médicament destiné au traitement des troubles liés à l&#39;hyperandrogénie, les compositions pharmaceutiques le contenant et un procédé de préparation à partir d&#39;Epilobium Parviflorum.
CA2137755A1 (fr) Attenuation des troubles a cellules falciformes par le phenyluree, le benzyluree ou le phenylethyluree ou par un homologue a substituant methoxyl, methyl ou hydroxyl sur le noyau
FR2794976B1 (fr) Compositions pharmaceutiques a action cicatrisante ou anti-complementaire comprenant un derive de dextrane
IL116828A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
EP0378413A3 (fr) Compositions pour le traitement topique de maladies cutanées
IT1213173B (it) Composti ad attivita&#39;antibatterica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
CA2264094A1 (fr) Eau structuree pour une meilleure hydratation

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed